Page last updated: 2024-08-26

bosentan anhydrous and torcetrapib

bosentan anhydrous has been researched along with torcetrapib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besler, C; Bigler, L; Dörries, C; Hermann, M; Lüscher, TF; Ruschitzka, F; Shaw, SG; Simic, B; Stalder, U1

Other Studies

1 other study(ies) available for bosentan anhydrous and torcetrapib

ArticleYear
Torcetrapib impairs endothelial function in hypertension.
    European heart journal, 2012, Volume: 33, Issue:13

    Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Aorta; Blood Pressure; Bosentan; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Hypertension; Immunohistochemistry; Intercellular Adhesion Molecule-1; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; Quinolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Renin-Angiotensin System; Sulfonamides; Superoxides; Vascular Cell Adhesion Molecule-1

2012